Answers are grounded in this paper and cite their sources.
Case report demonstrates flare phenomenon in bone metastases on PSMA PET/CT after ADT initiation, suggesting complex response in prostate cancer.
A 69-year-old man with newly diagnosed prostate cancer PSA 274 ng/mL, Gleason 4+3, T-stage 3b) underwent Ga-PSMA PET/CT for staging with follow-up scans 6 and 13 weeks after androgen deprivation therapy (ADT) initiation. Six weeks after ADT initiation, lymph node metastases observed at staging showed metabolic and radiological regression, whereas the skeleton showed increased PSMA uptake in existing bone metastases and several new PSMA-avid lesions. Skeletal PSMA uptake decreased after 13 weeks of ADT, and prostate-specific antigen decreased to 16 ng/mL. These findings suggest the presence of the flare phenomenon to ADT in bone metastases seen on PSMA PET/CT.
No takes yet. Share an insight, caveat, or question.
Zacho et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: